Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Optimizerx Corp (OPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,578
  • Shares Outstanding, K 12,014
  • Annual Sales, $ 12,130 K
  • Annual Income, $ -2,100 K
  • 36-Month Beta 0.92
  • Price/Sales 6.82
  • Price/Cash Flow N/A
  • Price/Book 7.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Computer - Software

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.00
  • Number of Estimates 3
  • High Estimate 0.01
  • Low Estimate -0.01
  • Prior Year -0.03
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.92 +26.51%
on 12/21/18
13.90 -18.81%
on 01/09/19
+1.74 (+18.29%)
since 12/18/18
3-Month
8.92 +26.51%
on 12/21/18
18.00 -37.31%
on 11/08/18
-6.07 (-34.96%)
since 10/18/18
52-Week
2.30 +390.65%
on 05/14/18
18.39 -38.64%
on 09/20/18
+8.98 (+390.65%)
since 05/14/18

Most Recent Stories

More News
OptimizeRx Announces Pricing of Public Offering of Common Stock

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced the pricing of the previously announced underwritten public offering...

OPRX : 11.28 (+5.07%)
OptimizeRx Announces Proposed Public Offering of Common Stock

OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, today announced a proposed underwritten public offering by WPP Luxembourg Gamma Three...

OPRX : 11.28 (+5.07%)
OptimizeRx Joins MSCI USA Microcap Index

OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, joined the MSCI USA Microcap Index at the conclusion of the MSCI indexes semi-annual reconstitution,...

OPRX : 11.28 (+5.07%)
OptimizeRx to Present at 11th Annual LD Micro Main Event on December 4-6, 2018

ROCHESTER, MI / ACCESSWIRE / November 28, 2018 / (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 11th Annual LD Micro Main...

OPRX : 11.28 (+5.07%)
Recent Analysis Shows Construction Partners, OptimizeRx, OncoMed Pharmaceuticals, Issuer Direct, Red Violet, and Golden Minerals Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Construction Partners, Inc....

OPRX : 11.28 (+5.07%)
ROAD : 11.15 (+3.82%)
RDVT : 7.20 (-0.14%)
OMED : 0.79 (+5.05%)
ISDR : 13.25 (-1.19%)
AUMN : 0.29 (-3.65%)
OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16

OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to ring the Nasdaq Stock Market Closing Bell on Friday, November 16, to...

OPRX : 11.28 (+5.07%)
OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS

OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the third quarter ended September 30, 2018. Quarterly comparisons are...

OPRX : 11.28 (+5.07%)
OptimizeRx (OPRX) Q3 Earnings Preview: What to Look Out For

OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OPRX : 11.28 (+5.07%)
OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018

OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate in the 4 Annual ROTH Technology Corporate Access Day being...

OPRX : 11.28 (+5.07%)
OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ET

OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Monday, November 5, 2018 at 4:30 p.m. Eastern time to discuss...

OPRX : 11.28 (+5.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade OPRX with:

Business Summary

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers...

See More

Key Turning Points

2nd Resistance Point 12.13
1st Resistance Point 11.71
Last Price 11.28
1st Support Level 10.80
2nd Support Level 10.31

See More

52-Week High 18.39
Fibonacci 61.8% 12.24
Last Price 11.28
Fibonacci 50% 10.34
Fibonacci 38.2% 8.45
52-Week Low 2.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar